Health Sciences Acquisitions Corporation 2 (HSAQ) Closes Orchestra BioMed Deal
by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26.

HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20 million from strategic partner Medtronic and additional investments by life sciences fund RTW.

Health Sciences 2 had about $67.7 million in its trust going into the vote after seeing 57.7% of shares redeemed in an earlier extension. Proceeds nonetheless exceeded the the transaction’s $60 million minimum cash condition.

The combined company will commence trading today on the Nasdaq under the symbol “OBIO”. Health Sciences 2 did not include warrants in its units when it IPO’d in August 2020.

The parties announced their $158 million deal with Orchestra BioMed in July 2022. New Hope, Pennsylvania-based Orchestra BioMed develops evidence-based therapeutic solutions for medical procedures that address major medical conditions, with a particular focus on cardiovascular diseases.


ADVISORS

  • Jefferies LLC and Piper Sandler & Co. acted as Joint Lead Placement Agents for the Series D Financing
  • Aegis Capital acted as Selling Agent.
  • Jefferies LLC is acting as lead financial advisor and a capital markets advisor to Orchestra BioMed.
  • Piper Sandler & Co. is acting as strategic advisor to Orchestra BioMed
  • Piper Sandler & Co. is acting as a capital markets advisor to Orchestra BioMed.
  • Chardan Capital Markets LLC is serving as financial and capital markets advisor to HSAC2
  • Barclays Capital Inc. is serving as financial and capital markets advisor to HSAC2.
  • Paul Hastings LLP is serving as legal counsel for Orchestra BioMed. Loeb & Loeb LLP is serving as legal counsel for HSAC2.
Recent Posts
by Nicholas Alan Clayton on 2024-03-18 at 1:32pm

News and Rumors PR: LatAm Logistic Properties, which has a pending combination with two (NYSE:TWOA), has secured a new $43 million 10-year lease for one of its properties in Peru. two is set to hold its completion vote on the deal March 25. TechCrunch: EV-maker Fisker (NYSE:FSR) has begun a six-week production pause as it...

by Nicholas Alan Clayton on 2024-03-18 at 8:06am

At the SPAC of Dawn Much of the action around SPAC votes this week is back-loaded towards Friday. Monday through Wednesday will see four extension votes and one completion vote, while Thursday and Friday is set to host three of each. The headliner of these completion votes is of course Digital World‘s (NASDAQ:DWAC) long-awaited special...

by Kristi Marvin on 2024-03-16 at 11:45am

Terms Tracker for the Week Ending March 15, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Maybe it’s the weather, but there was a perceptible change this week in the air. That’s not to say that we should expect a big...

by Nicholas Alan Clayton on 2024-03-15 at 1:34pm

Deals and Amendments Keyarch (NASDAQ:KYCH) has tweaked the earnout provision of its combination with EV charging firm ZOOZ Power. Under the new terms, ZOOZ shareholders will still receive 1,000,000 shares if it achieves $10 million or more in gross revenue for any four quarters within five or if its shares hit a VWAP of $12....

by Nicholas Alan Clayton on 2024-03-15 at 8:00am

In the current market conditions, SPACs looking for a target have to thread multiple needles at once. Many in the market now – particularly of the 2021 vintage – set out with teams experienced in high-growth technology sectors, but a risk-off market spooked by inflation has expressed itself in an appetite for more “sure things.”...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved